Skin Diseases, Genetic  >>  Eucrisa (crisaborole)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Eucrisa (crisaborole) / Pfizer
CORE 1, NCT02118766 / 2018-000731-27: Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Ages 2 Years and Older) With Atopic Dermatitis

Checkmark Mild-to-moderate atopic dermatitis
Jul 2015 - Jul 2015: Mild-to-moderate atopic dermatitis
Checkmark For mild-to-moderate atopic dermatitis
Jul 2015 - Jul 2015: For mild-to-moderate atopic dermatitis
Completed
3
763
US
AN2728 Topical Ointment, 2%, Matching vehicle control
Pfizer
Dermatitis, Atopic
04/15
04/15
CORE 2, NCT02118792: Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Aged 2 Years and Older) With Atopic Dermatitis

Checkmark For mild-to-moderate atopic dermatitis
Jul 2015 - Jul 2015: For mild-to-moderate atopic dermatitis
Completed
3
764
US
AN2728 Topical Ointment, 2%, Matching vehicle control
Pfizer
Dermatitis, Atopic
04/15
04/15

Download Options